Polychemotherapy in squamous cell carcinoma of the buccal mucosa.

@article{Dhawan1983PolychemotherapyIS,
  title={Polychemotherapy in squamous cell carcinoma of the buccal mucosa.},
  author={Indar K. Dhawan and Narbir S Thakur and Nishi Madan and Anjan Bannerjee and B K Sahoo},
  journal={Cancer},
  year={1983},
  volume={51 5},
  pages={773-7}
}
Thirty-nine patients with previously untreated squamous cell carcinoma of the buccal mucosa were treated by two polychemotherapeutic regimens. The first regimen consisted of bleomycin and methotrexate (BLM-MTX): bleomycin 30 mg was given intravenously twice weekly, and methotrexate 25 mg intravenously twice weekly for 2 1/2 and two weeks, respectively. The second program consisted of Cytoxan (cyclophosphamide), methotrexate and 5-FU (CMF): methotrexate 25 mg twice weekly for two weeks, Cytoxan… CONTINUE READING